Bonesupport Holding AB (publ) (FRA:2B4)
Germany
· Delayed Price · Currency is EUR 16.93
+0.13 (0.77%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Cerament Gentamicin and Ceramanent Vancomycin | 652.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cerament Gentamicin and Ceramanent Vancomycin Growth | 82.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cerament Bone Void Filler | 226.89M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cerament Bone Void Filler Growth | 1.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 19.04M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 95.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| North America | 715.94M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | 61.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom | 89.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom Growth | 21.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe and Rest of the World | 82.98M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe and Rest of the World Growth | 30.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sweden | 10.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sweden Growth | -6.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|